United States Biotechnology & Medical Research

Aardvark Therapeutics, Inc. (AARD)

Track

Track

Aardvark Therapeutics experienced four insider trading transactions recently, all involving sales by officer Nelson Sun totaling approximately $775,639. These disposals occurred following the company's August 2026 results financiers, while the stock price remains near its yearly lows. No recent purchases were recorded during this ninety-day period.
Ticker: AARD Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Aardvark Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.0
Sun Nelson See Remarks Officer
Transaction date
Planned sale
Price
309.43
Quantity 39,582 -25.9%
Value US$2,895,620
3.0
NELSON SUN Officer Officer
Transaction date
Proposed sale
Price
120.49
Quantity 69,823
Value US$1,291,700
3.0
Sun Nelson See Remarks Officer
Transaction date
Planned sale
Price
17.60
Quantity 65,059 +43.0%
Value US$1,331,408
3.0
NELSON SUN Officer Officer
Transaction date
Proposed sale
Price
4.92
Quantity 42,843
Value US$210,788
3.0
Sun Nelson Chief Financial Officer Officer
Transaction date
Purchase
Price
14.40
Quantity 3,000 +2.8%
Value US$43,200
3.7
Lee Tien-Li Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
14.49
Quantity 7,000 +0.5%
Value US$101,395
3.7
Lee Tien-Li Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
9.94
Quantity 3,500 +0.2%
Value US$34,805
3.7
Lee Tien-Li Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
9.51
Quantity 6,500 +0.4%
Value US$61,819
VICKERS VENT GLB DEEP-TECH FND I LP Director; 10% Stockholder Non-Executive Director Large shareholder
Transaction date
Proposed sale
Price
9.02
Quantity 10,360
Value US$93,413
3.7
Lee Tien-Li Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
8.50
Quantity 5,000 +0.3%
Value US$42,516
3.7
Lee Tien-Li Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
7.82
Quantity 6,000 +0.4%
Value US$46,926
3.7
Lee Tien-Li Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
7.91
Quantity 9,000 +0.6%
Value US$71,212
3.0
Sun Nelson Chief Financial Officer Officer
Transaction date
Purchase
Price
8.07
Quantity 6,000 +6.0%
Value US$48,440
VICKERS VENT GLB DEEP-TECH FND I LP Director; 10% Stockholder Non-Executive Director Large shareholder
Transaction date
Proposed sale
Price
8.72
Quantity 27,691
Value US$241,565
3.0
Sun Nelson Chief Financial Officer Officer
Transaction date
Purchase
Price
16.00
Quantity 10,000 +11.2%
Value US$160,000
3.7
Lee Tien-Li Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 16,542 +1.1%
Value US$264,672
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-11 2026-09-11 PlS Planned sale
3.0
Sun Nelson

See Remarks

Officer
39,582 -25.9%
309.43
US$2,895,620 		39,582 -25.9% 309.43 US$2,895,620
2026-09-11 2026-09-11 PrS Proposed sale
3.0
NELSON SUN

Officer

Officer
69,823
120.49
US$1,291,700 		69,823 120.49 US$1,291,700
2026-09-11 2026-09-10 PlS Planned sale
3.0
Sun Nelson

See Remarks

Officer
65,059 +43.0%
17.60
US$1,331,408 		65,059 +43.0% 17.60 US$1,331,408
2026-09-10 2026-09-10 PrS Proposed sale
3.0
NELSON SUN

Officer

Officer
42,843
4.92
US$210,788 		42,843 4.92 US$210,788
2025-12-12 2025-12-11 B Purchase
3.0
Sun Nelson

Chief Financial Officer

Officer
3,000 +2.8%
14.40
US$43,200 		3,000 +2.8% 14.40 US$43,200
2025-12-12 2025-12-11 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
7,000 +0.5%
14.49
US$101,395 		7,000 +0.5% 14.49 US$101,395
2025-09-16 2025-09-15 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
3,500 +0.2%
9.94
US$34,805 		3,500 +0.2% 9.94 US$34,805
2025-09-16 2025-09-15 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
6,500 +0.4%
9.51
US$61,819 		6,500 +0.4% 9.51 US$61,819
2025-09-15 2025-09-15 PrS Proposed sale
VICKERS VENT GLB DEEP-TECH FND I LP

Director; 10% Stockholder

Non-Executive Director Large shareholder
10,360
9.02
US$93,413 		10,360 9.02 US$93,413
2025-09-12 2025-09-12 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
5,000 +0.3%
8.50
US$42,516 		5,000 +0.3% 8.50 US$42,516
2025-09-12 2025-09-11 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
6,000 +0.4%
7.82
US$46,926 		6,000 +0.4% 7.82 US$46,926
2025-09-12 2025-09-10 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
9,000 +0.6%
7.91
US$71,212 		9,000 +0.6% 7.91 US$71,212
2025-09-10 2025-09-09 B Purchase
3.0
Sun Nelson

Chief Financial Officer

Officer
6,000 +6.0%
8.07
US$48,440 		6,000 +6.0% 8.07 US$48,440
2025-09-02 2025-09-02 PrS Proposed sale
VICKERS VENT GLB DEEP-TECH FND I LP

Director; 10% Stockholder

Non-Executive Director Large shareholder
20,000
8.51
US$170,118 		20,000 8.51 US$170,118
2025-08-28 2025-08-28 PrS Proposed sale
VICKERS VENT GLB DEEP-TECH FND I LP

Director; 10% Stockholder

Non-Executive Director Large shareholder
27,691
8.72
US$241,565 		27,691 8.72 US$241,565
2025-02-19 2025-02-14 B Purchase
Decheng Capital Global Life Sciences Fund IV, L.P.
Large shareholder
625,000 +187.5%
16.00
US$10,000,000 		625,000 +187.5% 16.00 US$10,000,000
2025-02-19 2025-02-14 B Purchase
Decheng Capital Global Life Sciences Fund IV, L.P.
Large shareholder
625,000 +26.8%
16.00
US$10,000,000 		625,000 +26.8% 16.00 US$10,000,000
2025-02-19 2025-02-14 B Purchase
3.0
Sun Nelson

Chief Financial Officer

Officer
10,000 +11.2%
16.00
US$160,000 		10,000 +11.2% 16.00 US$160,000
2025-02-19 2025-02-14 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
16,542 +1.1%
16.00
US$264,672 		16,542 +1.1% 16.00 US$264,672
2025-02-19 2025-02-14 B Purchase
3.7
Cormorant Asset Management, LP

Former 10% Owner
187,500 +23.4%
16.00
US$3,000,000 		187,500 +23.4% 16.00 US$3,000,000
Explore more

More insider trading research around Aardvark Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America